215 related articles for article (PubMed ID: 33455069)
1. N-glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas.
Kodama H; Yoneyama T; Tanaka T; Noro D; Tobisawa Y; Yamamoto H; Suto S; Hatakeyama S; Mori K; Yoneyama T; Hashimoto Y; Kakizaki I; Nakaji S; Ohyama C
Cancer Med; 2021 Feb; 10(4):1297-1313. PubMed ID: 33455069
[TBL] [Abstract][Full Text] [Related]
2. Aberrant N-Glycosylation Profile of Serum Immunoglobulins is a Diagnostic Biomarker of Urothelial Carcinomas.
Tanaka T; Yoneyama T; Noro D; Imanishi K; Kojima Y; Hatakeyama S; Tobisawa Y; Mori K; Yamamoto H; Imai A; Yoneyama T; Hashimoto Y; Koie T; Tanaka M; Nishimura SI; Kurauchi S; Takahashi I; Ohyama C
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29210993
[TBL] [Abstract][Full Text] [Related]
3. Significance of Serum N-glycan Profiling as a Diagnostic Biomarker in Urothelial Carcinoma.
Oikawa M; Hatakeyama S; Yoneyma T; Tobisawa Y; Narita T; Yamamoto H; Hashimoto Y; Koie T; Narita S; Sasaki A; Tsuchiya N; Habuchi T; Takahashi I; Nakaji S; Ohyama C
Eur Urol Focus; 2018 Apr; 4(3):405-411. PubMed ID: 28753809
[TBL] [Abstract][Full Text] [Related]
4. Detection of urothelial carcinoma, upper tract urothelial carcinoma, bladder carcinoma, and urothelial carcinoma with gross hematuria using selected urine-DNA methylation biomarkers: A prospective, single-center study.
Guo RQ; Xiong GY; Yang KW; Zhang L; He SM; Gong YQ; He Q; Li XY; Wang ZC; Bao ZQ; Li XS; Zhang K; Zhou LQ
Urol Oncol; 2018 Jul; 36(7):342.e15-342.e23. PubMed ID: 29706459
[TBL] [Abstract][Full Text] [Related]
5. A prognostic nomogram for the cancer-specific survival of patients with upper-tract urothelial carcinoma based on the Surveillance, Epidemiology, and End Results Database.
Li C; Yang J; Xu F; Han D; Zheng S; Kaaya RE; Wang S; Lyu J
BMC Cancer; 2020 Jun; 20(1):534. PubMed ID: 32513124
[TBL] [Abstract][Full Text] [Related]
6. Independent verification of circulating miRNA as diagnostic biomarkers for urothelial carcinoma.
Urabe F; Matsuzaki J; Takeshita F; Kishida T; Ochiya T; Hirai K
Cancer Sci; 2022 Oct; 113(10):3510-3517. PubMed ID: 35848873
[TBL] [Abstract][Full Text] [Related]
7. Alteration in serum concentrations of FGF19, FGF21, and FGF23 in patients with urothelial carcinoma.
Li JR; Chiu KY; Ou YC; Wang SS; Chen CS; Yang CK; Ho HC; Cheng CL; Yang CR; Chen CC; Wang SC; Lin CY; Hung SC; Hsu CY; Chen CJ
Biofactors; 2019 Jan; 45(1):62-68. PubMed ID: 30334297
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date.
Gomella LG; Mann MJ; Cleary RC; Hubosky SG; Bagley DH; Thumar AB; McCue PA; Lallas CD; Trabulsi EJ
Can J Urol; 2017 Feb; 24(1):8620-8626. PubMed ID: 28263126
[TBL] [Abstract][Full Text] [Related]
9. Identification of circulating microRNA signatures for upper tract urothelial carcinoma detection.
Tao J; Yang X; Li P; Wei J; Deng X; Cheng Y; Qin C; Ju X; Meng X; Li J; Gu M; Lu Q; Yin C
Mol Med Rep; 2015 Nov; 12(5):6752-60. PubMed ID: 26323574
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Genomic Profiling of Upper-tract and Bladder Urothelial Carcinoma.
Necchi A; Madison R; Pal SK; Ross JS; Agarwal N; Sonpavde G; Joshi M; Yin M; Miller VA; Grivas P; Chung JH; Ali SM
Eur Urol Focus; 2021 Nov; 7(6):1339-1346. PubMed ID: 32861617
[TBL] [Abstract][Full Text] [Related]
11. The neutrophil-to-lymphocyte ratio as a predictor of intravesical recurrence in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.
Kishimoto N; Takao T; Kuribayashi S; Yamamichi G; Nakano K; Kawamura M; Tsutahara K; Tanigawa G; Yamaguchi S
Int J Clin Oncol; 2017 Feb; 22(1):153-158. PubMed ID: 27614622
[TBL] [Abstract][Full Text] [Related]
12. Risk of urothelial cancer death among people using antihypertensive drugs-a cohort study from Finland.
Santala EEE; Kotsar A; Veitonmäki T; Tammela TLJ; Murtola TJ
Scand J Urol; 2019 Aug; 53(4):185-192. PubMed ID: 31250699
[No Abstract] [Full Text] [Related]
13. Machine learning diagnosis by immunoglobulin N-glycan signatures for precision diagnosis of urological diseases.
Iwamura H; Mizuno K; Akamatsu S; Hatakeyama S; Tobisawa Y; Narita S; Narita T; Yamashita S; Kawamura S; Sakurai T; Fujita N; Kodama H; Noro D; Kakizaki I; Nakaji S; Itoh K; Tsuchiya N; Ito A; Habuchi T; Ohyama C; Yoneyama T
Cancer Sci; 2022 Jul; 113(7):2434-2445. PubMed ID: 35524940
[TBL] [Abstract][Full Text] [Related]
14. A Urine-based Genomic Assay Improves Risk Stratification for Patients with High-risk Hematuria Stratified According to the American Urological Association Guidelines.
de Jong JJ; Pijpers OM; van Kessel KEM; Boormans JL; Van Criekinge W; Zwarthoff EC; Lotan Y
Eur Urol Oncol; 2023 Apr; 6(2):183-189. PubMed ID: 36089502
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive genomic profiling of upper tract urothelial carcinoma and urothelial carcinoma of the bladder identifies distinct molecular characterizations with potential implications for targeted therapy & immunotherapy.
Tang Q; Zuo W; Wan C; Xiong S; Xu C; Yuan C; Sun Q; Zhou L; Li X
Front Immunol; 2022; 13():1097730. PubMed ID: 36818471
[TBL] [Abstract][Full Text] [Related]
16. Second-line Pembrolizumab for Metastatic Urothelial Carcinoma: Differences in Treatment Outcomes According to the Primary Site.
Nishiyama N; Kita Y; Ito K; Kato M; Hatakeyama S; Matsushita Y; Naito S; Miyake M; Nakanishi S; Kato Y; Shibuya T; Hayashi T; Yasumoto H; Yoshida T; Uemura M; Taoka R; Nishiyama H; Kobayashi T; Kitamura H;
Anticancer Res; 2023 Nov; 43(11):5041-5050. PubMed ID: 37909969
[TBL] [Abstract][Full Text] [Related]
17. HOXA9, PCDH17, POU4F2, and ONECUT2 as a Urinary Biomarker Combination for the Detection of Bladder Cancer in Chinese Patients with Hematuria.
Wu Y; Jiang G; Zhang N; Liu S; Lin X; Perschon C; Zheng SL; Ding Q; Wang X; Na R; Sun J; Xu J
Eur Urol Focus; 2020 Mar; 6(2):284-291. PubMed ID: 30309818
[TBL] [Abstract][Full Text] [Related]
18. LC-MS based urine untargeted metabolomic analyses to identify and subdivide urothelial cancer.
Yang M; Liu X; Tang X; Sun W; Ji Z
Front Oncol; 2023; 13():1160965. PubMed ID: 37256175
[TBL] [Abstract][Full Text] [Related]
19. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Böhle A; Van Rhijn BW; Kaasinen E; Palou J; Shariat SF
Eur Urol; 2015 Nov; 68(5):868-79. PubMed ID: 26188393
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility and concordance of upper urinary tract cytology and biopsy in predicting clinicopathological features of upper urinary tract urothelial carcinoma.
Simon CT; Skala SL; Weizer AZ; Ambani SN; Chinnaiyan AM; Palapattu G; Hafez K; Magers MJ; Kaffenberger SD; Spratt DE; Montgomery JS; Morgan TM; Udager AM; Lew M; Mehra R
Hum Pathol; 2019 Apr; 86():76-84. PubMed ID: 30537495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
